LIVN vs SNY
LivaNova PLC (LIVN) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
LivaNova PLC (LIVN) is a medical devices company listed on NASDAQ.
SNY (SNY) common stock.
Latest reported LIVN revenue for 2026-06-30 was $752.8M. Net income was $130.9M. LIVN currently screens at market cap $4.40B and trailing P/E 40.8.
SNY does not have a complete income-statement cache yet.
LIVN currently screens at market cap $4.40B and trailing P/E 40.8. SNY currently screens at market cap $0.
Not investment advice. Open the LIVN and SNY stock pages for the full models.
Not investment advice.